[
    [
        {
            "time": "2021-01-05",
            "original_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
            "features": {
                "keywords": [
                    "生物类似药",
                    "定价",
                    "价格战",
                    "集采"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-05",
            "original_text": "新冠疫苗研发进度不占优，西藏药业是转型还是“讲故事”？董事长陈达彬：项目不是没有进展，有中长期的战略考虑",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "研发进度",
                    "转型",
                    "战略考虑"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新冠疫苗研发进度不占优，西藏药业是转型还是“讲故事”？董事长陈达彬：项目不是没有进展，有中长期的战略考虑",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-05",
            "original_text": "郭广昌豪饮白酒：豫园股份控股舍得，三连涨停市值增长百亿",
            "features": {
                "keywords": [
                    "郭广昌",
                    "豫园股份",
                    "舍得",
                    "三连涨停"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "郭广昌豪饮白酒：豫园股份控股舍得，三连涨停市值增长百亿",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-05",
            "original_text": "复星系豫园股份业绩大增 为何资本市场并不买单？",
            "features": {
                "keywords": [
                    "复星系",
                    "豫园股份",
                    "业绩大增",
                    "资本市场"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星系豫园股份业绩大增 为何资本市场并不买单？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-05",
            "original_text": "45.3亿元竞得ST舍得控股权 豫园股份连续三日涨停",
            "features": {
                "keywords": [
                    "豫园股份",
                    "ST舍得",
                    "控股权",
                    "涨停"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "45.3亿元竞得ST舍得控股权 豫园股份连续三日涨停",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-05",
            "original_text": "创新药研发进入高速发展期 2021医药行业未来投资趋势预测",
            "features": {
                "keywords": [
                    "创新药",
                    "研发",
                    "高速发展",
                    "投资趋势"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "创新药研发进入高速发展期 2021医药行业未来投资趋势预测",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]